Predictive Oncology Inc.
NASDAQ:POAI
Overview | Financials
Company Name | Predictive Oncology Inc. |
Symbol | POAI |
Currency | USD |
Price | 1.19 |
Market Cap | 7,933,718 |
Dividend Yield | 0% |
52-week-range | 0.55 - 3.76 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Raymond F. Vennare |
Website | https://www.predictive-oncology.com |
An error occurred while fetching data.
About Predictive Oncology Inc.
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD